Skip to main content
Labor, Employment and Immigration Update

Final FDA Approval of Pfizer-BioNTech Vaccine Clears a Path for Employers to Mandate Vaccines

August 23, 2021
The U.S. Food and Drug Administration (FDA) today issued full approval for the Pfizer-BioNTech COVID-19 vaccine, now marketed as Comirnaty, clearing a path for more employers and other institutions to mandate vaccinations. While lawsuits challenging vaccine mandates by private employers have failed to gain much traction thus far, the mere potential for litigation over vaccine mandates when COVID-19 vaccines were available only under the FDA’s emergency use authorization complicated many employers’ decisions over whether to issue such mandates. With voluntary vaccination incentive programs having largely played out, the FDA’s full approval of the Pfizer vaccine is welcome news for employers who wish to mandate the vaccine as a means toward fulfilling their responsibilities under the Occupational Safety and Health Act (OSHA) to provide a safe work environment for their workforces.

律师广告—Sidley Austin LLP 是一家全球性律师事务所。我们的地址及联系方式可在 www.sidley.com/en/locations/offices 查阅。

Sidley 提供本信息仅作为向客户及其他友好人士提供的服务,且仅供教育目的使用。本信息不应被解释或依赖为法律意见,亦不构成律师与客户关系。读者在未寻求专业顾问意见之前,不应依据本信息采取任何行动。Sidley 和 Sidley Austin 指 Sidley Austin LLP 及其关联合伙实体,详见 www.sidley.com/disclaimer

© Sidley Austin LLP

Related Resources